AIA Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-64,391
| Closed | -$1.98M | – | 295 |
|
|
2023
Q3 | $1.98M | Buy |
64,391
+11,198
| +21% | +$344K | 0.1% | 106 |
|
|
2023
Q2 | $2.13M | Sell |
53,193
-5,644
| -10% | -$226K | 0.1% | 98 |
|
|
2023
Q1 | $2.4M | Buy |
58,837
+32,702
| +125% | +$1.33M | 0.13% | 67 |
|
|
2022
Q4 | $1.01M | Sell |
26,135
-17,349
| -40% | -$670K | 0.06% | 139 |
|
|
2022
Q3 | $2.31M | Buy |
43,484
+1,452
| +3% | +$77.2K | 0.15% | 61 |
|
|
2022
Q2 | $2.45M | Sell |
42,032
-6,092
| -13% | -$355K | 0.13% | 72 |
|
|
2022
Q1 | $3.67M | Sell |
48,124
-74,642
| -61% | -$5.7M | 0.16% | 54 |
|
|
2021
Q4 | $7.39M | Buy |
122,766
+46,385
| +61% | +$2.79M | 0.35% | 43 |
|
|
2021
Q3 | $4.28M | Buy |
76,381
+12,983
| +20% | +$727K | 0.24% | 63 |
|
|
2021
Q2 | $3.56M | Buy |
63,398
+2,553
| +4% | +$143K | 0.24% | 62 |
|
|
2021
Q1 | $4.27M | Buy |
60,845
+21,661
| +55% | +$1.52M | 0.62% | 48 |
|
|
2020
Q4 | $2.8M | Buy |
+39,184
| New | +$2.8M | 0.32% | 47 |
|